These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4992983)

  • 1. DNA antibodies in childhood scleroderma.
    Hanson V; Drexler E; Kornreich H
    Arthritis Rheum; 1970; 13(6):798-801. PubMed ID: 4992983
    [No Abstract]   [Full Text] [Related]  

  • 2. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
    Hanson V; Kornreich HK; Drexler E; Johnson GD; Macpherson GA
    Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopathologic findings in systemic sclerosis patients: clinical and immunopathologic relationships.
    Shibeshi D; Blaszczyk M; Jarzabek-Chorzelska M; Jablońska S; Chorzelski T
    Int J Dermatol; 1989 Dec; 28(10):650-6. PubMed ID: 2512263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to double-stranded DNA. A comparison of the indirect immunofluorescent test using crithidia luciliae and the DNA-binding assay.
    Deegan MJ; Walker SE; Lovell SE
    Am J Clin Pathol; 1978 Jun; 69(6):599-604. PubMed ID: 352134
    [No Abstract]   [Full Text] [Related]  

  • 6. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 7. The gammaG subclass of antinuclear and antinucleic acid antibodies.
    Schur PH; Monroe M; Rothfield N
    Arthritis Rheum; 1972; 15(2):174-82. PubMed ID: 4554890
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-IgG and antinuclear antibodies in juvenile rheumatoid arthritis.
    Munthe E
    Scand J Rheumatol; 1972; 1(4):161-70. PubMed ID: 4541440
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in systemic scleroderma.
    Swierczynska Z; Rdultowska H; Blaszczyk M; Jablonska S; Luft S
    Immunol Commun; 1984; 13(5):433-8. PubMed ID: 6335127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers of systemic scleroderma in children.
    Błaszczyk M; Jabłońska S; Szymańska-Jagiełło W; Jarzabek-Chorzelska M; Chorzelski T
    Pediatr Dermatol; 1991 Mar; 8(1):13-20. PubMed ID: 1907369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-nucleic acid antibodies in children with systemic lupus erythematosus and systemic scleroderma and in their relatives living with the probands].
    Adamashvili IM; Makarova OV; Zamchuk LA; Gvardzhaladze TV
    Revmatologiia (Mosk); 1991; (4):13-6. PubMed ID: 1725222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of antinuclear factors using the immunologic enzyme technic].
    Storch H
    Z Gesamte Inn Med; 1973 Jan; 28(2):29-32. PubMed ID: 4120838
    [No Abstract]   [Full Text] [Related]  

  • 14. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct immunofluorescent findings in scleroderma syndromes.
    Connolly SM; Winkelmann RK
    Acta Derm Venereol; 1981; 61(1):29-36. PubMed ID: 6164211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
    Takehara K; Moroi Y; Ishibashi Y
    Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinuclear antibodies, antiperinuclear factor and rheumatoid factors in a group of children with collagen diseases].
    Vaccaro R; Rossoni R; Alestra P
    Minerva Pediatr; 1967 Dec; 19(49):2181-6. PubMed ID: 4885636
    [No Abstract]   [Full Text] [Related]  

  • 18. Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions.
    Sontheimer RD; Deng JS; Gilliam JN
    J Am Acad Dermatol; 1983 Sep; 9(3):335-43. PubMed ID: 6415131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.